pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Aug 27, 26
Revolution pancreatic cancer drug should quickly become a blockbuster, analysts say
biopharma dive
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 27, 26
STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
stat
Aug 27, 26
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
stat
Aug 27, 26
Decoding DEA action on kratom-related substances
stat
Aug 27, 26
RevMed could become ‘next oncology titan’ with Rasonque nod
biospace
Aug 27, 26
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
biospace
Aug 27, 26
Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
stat
Aug 27, 26
STAT+: The mystery of Moderna’s magic algorithm
stat
Aug 27, 26
Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug
fiercebiotech
Aug 26, 26
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
biospace
Aug 26, 26
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
biopharma dive
Aug 26, 26
RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drug
biospace
Aug 26, 26
Biohaven trades cash for ‘upside’ with $795M epilepsy drug deal
biopharma dive
Aug 26, 26
Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns
endpoints
Aug 26, 26
FDA approves Revolution Medicines' pancreatic cancer drug
endpoints
Aug 26, 26
STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
stat
Aug 26, 26
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
fda press
Aug 26, 26
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
biopharma dive
Aug 26, 26
Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pending
biospace
Aug 26, 26
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
biospace
Aug 26, 26
Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera
biospace
Aug 26, 26
FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
fiercebiotech
Aug 26, 26
FDA eyes 2 new deputy commissioner posts: Report
biospace
Aug 26, 26
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
fiercebiotech
Aug 26, 26
Beyond the Bandwidth Ceiling: Redesigning Advanced Therapy Operating Models for the Digital Staff Era
fiercebiotech
Aug 26, 26
Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
stat
Aug 26, 26
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
stat
Aug 26, 26
FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis
fiercebiotech
Aug 26, 26
Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh
biospace
← prev
page 28 of 52
next →